Navigation Links
New 2009 Cumulative Supplement to Pharmaceutical Patent Law Examines Critical Intersection Of Patent Law and Food And Drug Law

ARLINGTON, Va., Oct. 14 /PRNewswire-USNewswire/ -- The 2009 Cumulative Supplement to Pharmaceutical Patent Law delivers the latest legal developments in pharmaceutical patent law. Published by BNA Books, a division of BNA, Pharmaceutical Patent Law is supplemented annually and provides complete coverage of intricate topics, including the antitrust implications of patent settlements; the experimental use privilege; and international aspects of the field, including comparative data protection laws, the benefits and limitations of the Paris Convention, the Patent Cooperation Treaty, Foreign Filing Licenses, regional agreements, and the TRIPS agreement.

(Logo: )

The 2009 Cumulative Supplement includes the following new information:

  • Legislative developments in the 111th Congress concerning patents, follow-on biologics, and Hatch-Waxman reform
  • The continuing impact of Supreme Court precedent upon pharmaceutical patent law, including the law of obviousness and declaratory judgment jurisdiction
  • The new rules concerning the extension of the Hatch-Waxman Act's 30-month stay of marketing approval
  • Coverage of judicial reaction to concerns over baseless Paragraph IV ANDA filings
  • Updated information on the construction of pharmaceutical patent claims

Pharmaceutical Patent Law not only reviews current issues of importance, but identifies topics such as parallel importation and authorized generics that are likely to be of growing significance. The treatise is invaluable to the busy practitioner who must keep on track in this evolving area of the law. The author, Professor John R. Thomas, is a member of the faculty of Georgetown University Law Center, Washington, DC, where he teaches courses in both patent and food and drug law. A widely published author in the field of pharmaceutical patent law, he frequently serves as a Special Master in patent litigation before the federal courts.

BNA is a leading private publisher of news and information products for professionals in law and business. In addition to Pharmaceutical Patent Law, BNA's Book Division publishes Biotechnology and the Federal Circuit; Drafting Patent License Agreements; Electronic and Software Patents: Law and Practice; Intellectual Property Taxation: Transaction and Litigation Issues; International Patent Litigation: A Country-by-Country Analysis; Patent Infringement Remedies; Patent Law and Practice; Patent Prosecution: Law, Practice, and Procedure; Patent, Trademark, and Copyright Laws; Patent, Trademark, and Copyright Regulations; Patents and the Federal Circuit; Pharmaceutical Patent Law; Harmon on Patents: Black-Letter Law and Commentary; and other titles in legal specialties. The BNA Books website, including an online catalog, can be found at

The new 2009 Cumulative Supplement to Pharmaceutical Patent Law may be purchased alone (Order #1824-PRY9/$225.00 plus tax, shipping, and handling) or with the main volume (Order #9824-PRY9/$390.00 plus tax, shipping, and handling) from BNA Books, PO Box 7814, Edison, NJ 08818-7814. Telephone orders: 1-800-960-1220. Fax orders: 1-732-346-1624. For a free BNA Books catalog, call 1-800-960-1220 or send an e-mail request to A 10% discount is available on print copies of books when ordered from the website at (Please note that discounts cannot be combined).


Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. PartnerRe Declares Dividends on Series C Cumulative Redeemable Preferred Shares and Series D Cumulative Redeemable Preferred Shares and Corrects Ex-Dividend Trading Date for Common Shares
2. Cumulative radiation exposure shows increased cancer risk for emergency department patients
3. EPA should pursue cumulative risk assessment of phthalates and other chemicals
4. Antioxidant Supplements May Raise Womens Skin Cancer Risk
5. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
6. LifeQuest World Corporation Proud Contributor to Dietary Supplement Education Alliance (DSEA)
7. Vitamin D Supplements May Lengthen Life
8. American Heart Association Surgical Supplement Journal Report: Appropriate Hospital Discharge System Can Prevent Future Cardiac Events
9. U of M study: Health food supplement may curb addiction of pathological gamblers
10. Joint Juice Launches New Ready-to-Drink Glucosamine & Vitamin-Enhanced Dietary Supplement Water Nationwide
11. Wellcorps International Unveils New Nutritional Supplements
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article published ... Association meeting in Washington D.C. revolved around the fact that proper dental care, both ... talk stressed the link between periodontal disease (more commonly referred to as gum disease) ...
(Date:11/27/2015)... PA (PRWEB) , ... November 27, 2015 , ... ... be a safe and convenient way to dispense prescription medications at home, so ... and effective way to monitor and dispense prescription medications. In doing so, it ...
(Date:11/27/2015)... ... ... MPWH, the No.1 Herpes-only dating community in the world, revealed that over 50% of its ... 3.7 billion people under the age of 50 – or 67% of the population - ... estimates of HSV-1 infection . , "The data shocks us highly!" said Michelle Li, ...
(Date:11/27/2015)... ... November 27, 2015 , ... Keeping ... platform for mental health and wellness consultation, has collaborated with a leading web-based ... the knowledge gap experienced by parents and bring advice from parenting experts within ...
(Date:11/27/2015)... , ... November 27, 2015 , ... ... center software Q-Suite, announces the incorporation of Asterisk 11 LTS (Long Term Support) ... supported Asterisk 11 LTS brings Q-Suite 5.10 up-to-date with a version of Asterisk ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... 2015 ... "2016 Global Tumor Marker Testing Market: ... Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, ... their offering. --> ) ... "2016 Global Tumor Marker Testing Market: Supplier ...
(Date:11/26/2015)... UTRECHT , Países Bajos, November 26, 2015 /PRNewswire/ ... con la terapia fotodinámica de Bremachlorin para el cáncer ... combina la inmunoterapia con la terapia fotodinámica de Bremachlorin ... Un nuevo enfoque combina la inmunoterapia con la ...   Clinical Cancer Research . --> ...
(Date:11/26/2015)... , November 26, 2015 ... new combination approach blends immunotherapy with Bremachlorin-photodynamic therapy for ... combination approach blends immunotherapy with Bremachlorin-photodynamic therapy for advanced ... combination approach blends immunotherapy with Bremachlorin-photodynamic therapy for advanced ... has found that immunotherapy can be efficiently combined ...
Breaking Medicine Technology: